11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone

American Journal of Hematology
A OhshimaA B Miura

Abstract

We report on 2 patients with acute leukemia who had an 11q23 chromosomal aberration as an additional change after treatment with etoposide and mitoxantrone, agents that affect topoisomerase II (Topo II). One patient with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (L2) received chemotherapy, including 1,000 mg of etoposide and 75 mg of mitoxantrone. She relapsed 10 months later. Analysis at time of relapse showed a chromosomal aberration of del(11)(q23) as an additional cytogenetic change. The other patient was diagnosed with acute monoblastic leukemia (M5a) and received two autologous peripheral blood stem-cell transplantations. Her cumulative doses of etoposide and mitoxantrone were 6,000 mg and 42 mg, respectively. She also relapsed, and analysis at that time revealed del(11)(q23) as an additional chromosomal aberration. The mixed lineage leukemia/myeloid-lymphoid leukemia (MLL) gene was not rearranged in either case, making these cases distinct from previously described therapy-related leukemias caused by Topo II inhibitors. Based on these two cases, it may be that Topo II inhibitors can cause clonal evolution affecting chromosome band 11q23.

Citations

Dec 6, 2008·Blood·Joerg FaberScott A Armstrong
Jul 10, 2007·DNA Repair·Dorothee C Dartsch, Frank Gieseler
Dec 31, 2009·Apoptosis : an International Journal on Programmed Cell Death·Ilona SchonnDorothee C Dartsch
Sep 28, 1998·Biochimica Et Biophysica Acta·A K Larsen, A Skladanowski
Apr 30, 2011·Archives of Pathology & Laboratory Medicine·Amy Heerema-McKenneyUNKNOWN Members of Cancer Committee, College of American Pathologists

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Medical and Pediatric Oncology
A SchiavettiM A Castello
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
F SirzénR Lewensohn
International Journal of Cancer. Journal International Du Cancer
Lasse Tengbjerg HansenThomas Helleday
© 2021 Meta ULC. All rights reserved